Skip to content
healthcare.dev

KYGEVVI

NDC 50474-350, doxecitine and doxribtimine, powder, for solution, from UCB, Inc..

Product NDC
50474-350
Status
Listed
Labeler
UCB, Inc.
Dosage form
POWDER, FOR SOLUTION
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA219792
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50474-350 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXECITINE2 g/1
  • DOXRIBTIMINE2 g/1
Package NDCNDC-11Package
50474-350-305047403503030 PACKET in 1 CARTON (50474-350-30) / 1 POWDER, FOR SOLUTION in 1 PACKET (50474-350-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7d5ce670-9314-4fd7-8b0a-1447910dcf9e

Use it

Look up 50474-350 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50474-350 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50474-350. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.